New Rufomycins from Streptomyces atratus MJM3502 Expand Anti- Mycobacterium tuberculosis Structure-Activity Relationships

被引：4

作者：

Zhou, Bin ^{[1
,2
,3
,4
]}

Shetye, Gauri ^{[3
]}

Wolf, Nina M. ^{[3
]}

Chen, Shao-Nong ^{[1
,2
,3
]}

Qader, Mallique ^{[3
]}

Ray, G. Joseph ^{[1
,2
,3
]}

Lankin, David C. ^{[1
,2
,3
]}

Cho, Sanghyun ^{[3
]}

Cheng, Jinhua ^{[5
]}

Suh, Joo-Won ^{[5
]}

Franzblau, Scott G. ^{[1
,2
,3
]}

McAlpine, James B. ^{[1
,2
,3
]}

Pauli, Guido F. ^{[1
,2
,3
]}

机构：

[1] Univ Illinois, Pharmacognosy Inst, Coll Pharm, Chicago, IL 60612 USA

[2] Univ Illinois, Dept Pharmaceut Sci Coll Pharm, Chicago, IL 60612 USA

[3] Univ Illinois, Inst TB Res, Coll Pharm, Chicago, IL 60612 USA

[4] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China

[5] Myongji Univ, Myongji Bioefficacy Res Ctr, Yongin 17058, Gyeonggi Do, South Korea

来源：

ORGANIC LETTERS | 2022年

基金：

美国国家卫生研究院;

关键词：

ABSOLUTE-CONFIGURATION;

D O I：

10.1021/acs.orglett.2c02493

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

Four new rufomycins, compounds 1-4, named rufomycins 56, 57, 58, and 61, respectively, exhibiting new skeletal features, were obtained from Streptomyces atratus strain MJM3502 and were fully characterized. Compounds 1 and 2 possess a 4imidazolidinone ring not previously encountered in this family of cyclopeptides, thereby resulting in a [5,17] bicyclic framework. The in vitro anti -Mycobacterium tuberculosis potency of compounds 3 and 4 is remarkable, with minimum inhibitory concentration values of 8.5 and 130 nM, respectively.

引用

页码：7265 / 7270

页数：6

共 50 条

[21] Anti-Barnacle Activities of Isothiocyanates Derived from β-Citronellol and Their Structure-Activity Relationships
Tanikawa, Aina
Fujihara, Takaya
Nakajima, Natsumi
Maeda, Yuka
Nogata, Yasuyuki
Yoshimura, Erina
Okada, Yohei
Chiba, Kazuhiro
Kitano, Yoshikazu
CHEMISTRY & BIODIVERSITY, 2023, 20 (02)
[22] Quantitative structure-activity relationship and molecular docking of 4-Alkoxy-Cinnamic analogues as anti-mycobacterium tuberculosis
Adeniji, Shola Elijah
Uba, Sani
Uzairu, Adamu
JOURNAL OF KING SAUD UNIVERSITY SCIENCE, 2020, 32 (01) : 67 - 74
[23] Structure-activity relationships of compounds targeting mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate synthase
Mao, Jialin
Eoh, Hyungjin
He, Rong
Wang, Yuehong
Wan, Baojie
Franzblau, Scott G.
Crick, Dean C.
Kozikowski, Alan P.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (19) : 5320 - 5323
[24] Imidazolidines as new anti-Trypanosoma cruzi agents:: Biological evaluation and structure-activity relationships
Caterina, M. Cristina
Perillo, Isabel A.
Boiani, Lucfa
Pezaroglo, Horacio
Cerecetto, Hugo
Gonzalez, Mercedes
Salerno, Alejandra
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (05) : 2226 - 2234
[25] Structure-Activity Relationships of a Diverse Class of Halogenated Phenazines That Targets Persistent, Antibiotic-Tolerant Bacterial Biofilms and Mycobacterium tuberculosis
Garrison, Aaron T.
Abouelhassan, Yasmeen
Norwood, Verrill M.
Kallifidas, Dimitris
Bai, Fang
Minh Thu Nguyen
Rolfe, Melanie
Burch, Gena M.
Jin, Shouguang
Luesch, Hendrik
Huigens, Robert W., III
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (08) : 3808 - 3825
[26] First Y-type actinomycins from Streptomyces with divergent structure-activity relationships for antibacterial and cytotoxic properties
Bitzer, Jens
Streibel, Martin
Langer, Hans-Joerg
Grond, Stephanie
ORGANIC & BIOMOLECULAR CHEMISTRY, 2009, 7 (03) : 444 - 450
[27] Anti-Proliferative Activities of Terpenoids Isolated from Alisma orientalis and their Structure-Activity Relationships
Xu, Wen
Li, Ting
Qiu, Jian-Fang
Wu, Shui-Sheng
Huang, Ming-Qing
Lin, Li-Gen
Zhang, Qing-Wen
Chen, Xiu-Ping
Lu, Jin-Jian
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2015, 15 (02) : 228 - 235
[28] Anti-inflammatory evaluation and structure-activity relationships of diterpenoids isolated from Euphorbia hylonoma
Wei, Wen-Jun
Qi, Weiyan
Gao, Xin-Mei
Feng, Ke-Na
Ma, Kai-Liang
Li, Hang-Ying
Li, Ya
Gao, Kun
BIOORGANIC CHEMISTRY, 2019, 93
[29] Structure-activity relationship for adenosine kinase from Mycobacterium tuberculosis.: II.: Modifications to the ribofuranosyl moiety
Long, Mary C.
Shaddix, Sue C.
Moukha-Chafiq, Omar
Maddry, Joseph A.
Nagy, Lisa
Parker, William B.
BIOCHEMICAL PHARMACOLOGY, 2008, 75 (08) : 1588 - 1600
[30] Quantitative structure-activity relationships and design of thymine-like inhibitors of thymidine monophosphate kinase of Mycobacterium tuberculosis with favourable pharmacokinetic profiles
Keita, M.
Kumar, A.
Dali, B.
Megnassan, E.
Siddiqi, M. I.
Frecer, V.
Miertus, S.
RSC ADVANCES, 2014, 4 (99) : 55853 - 55866

← 1 2 3 4 5 →